Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blinded, Randomized Placebo-controlled Trial of 40 Hz Light Neurostimulation Therapy for Patients With Depression

NCT05680220 is registered in ClinicalTrials.gov with Klaus Martiny as lead sponsor.

NCT NCT05680220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05680220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blinded, Randomized Placebo-controlled Trial of 40 Hz Light Neurostimulation Therapy for Patients With Depression
Lead sponsor
Klaus Martiny
Phase
Not applicable
Overall status
Recruiting
Start date
October 5, 2023
Completion date
July 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, treatment resistant depression